Illicit trade activity (ITA) in the pharmaceutical industry has been on a steady rise globally since the Pharmaceutical Security Institute (PSI) began reporting annual incident statistics more than 22 ...

2024 was a pivotal year for the patient support landscape, as the space underwent a substantial shift shaped by market dynamics, regulatory changes, and the evolving needs of patients. After a quarter ...

The pharmaceutical industry has witnessed a resurgence of mergers and acquisitions (M&As) as companies seek to gain a competitive edge, accelerate innovation, and drive growth. By consolidating ...

A bipartisan government funding deal at the end of last year initially included reforms of pharmacy benefit managers (PBMs) that would limit their ability to use rebates as a major profit center. PBM ...

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, James Shehan, chair of the FDA Regulatory practice at Lowenstein Sandler, describes what the approach of pharma ...

A survey study of US employers aims to determine whether they prioritize financial or nonfinancial criteria when selecting health plans. Being that many individuals found themselves on an ...

A cohort study investigates the magnitude of lost coverage among pediatric patients, following the conclusion of the pandemic public health emergency. After the start of the COVID-19 pandemic in 2020, ...

New engagement approaches can help drive treatment gains in underrepresented communities. There is no doubt that diversity of those who participate in clinical trials is of utmost importance, but, ...

Welcome to the second installment of the “Popping the Gross-to-Net Bubble” series. In this column, I’ll dive into actionable steps pharmaceutical manufacturers can take to address this issue. This ...

A report offers a comprehensive benchmarking and assessment of pharmaceutical manufacturer engagement with specialty pharmacies. The specialty pharmacy channel plays a pivotal role in supporting ...

However, the 10% tariff on imports from China went into effect this morning, with the nation imposing several of it own. The pause will allow time for negotiations on the immigration (via increased ...

In a video interview with Pharma Commerce, Alex Guillen, global pharma and life sciences director at Tive, highlights a significant concern: the rapid advancement of technology and its potential ...